{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:22:12Z","timestamp":1779178932228,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institute of Cancer","doi-asserted-by":"crossref","award":["R44CA217400"],"award-info":[{"award-number":["R44CA217400"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["R43EY028779"],"award-info":[{"award-number":["R43EY028779"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R43GM128369"],"award-info":[{"award-number":["R43GM128369"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.drudis.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T16:55:15Z","timestamp":1589302515000},"page":"1298-1306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["SCHOOL of nature: ligand-independent immunomodulatory peptides"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-1800","authenticated-orcid":false,"given":"Alexander B.","family":"Sigalov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.05.005_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/self.1.2.11590","article-title":"The SCHOOL of nature: I. Transmembrane signaling","volume":"1","author":"Sigalov","year":"2010","journal-title":"Self Nonself."},{"key":"10.1016\/j.drudis.2020.05.005_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-5699(92)90136-U","article-title":"Multichain immune recognition receptors: similarities in structure and signaling pathways","volume":"13","author":"Keegan","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.drudis.2020.05.005_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41423-020-0367-1","article-title":"Structural understanding of T cell receptor triggering","volume":"17","author":"Xu","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.182.2.439","article-title":"Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness","volume":"182","author":"Abastado","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2020.05.005_bib0025","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41423-018-0003-5","article-title":"TREM-1 multimerization is essential for its activation on monocytes and neutrophils","volume":"16","author":"Carrasco","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0035","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1021\/bi035900h","article-title":"Homooligomerization of the cytoplasmic domain of the T cell receptor z chain and of other proteins containing the immunoreceptor tyrosine-based activation motif","volume":"43","author":"Sigalov","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2020.05.005_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jmb.2013.09.036","article-title":"The cytoplasmic domain of the T-cell receptor zeta subunit does not form disordered dimers","volume":"426","author":"Nourse","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.it.2004.08.009","article-title":"Multichain immune recognition receptor signaling: different players, same game?","volume":"25","author":"Sigalov","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2006.08.004","article-title":"Immune cell signaling: a novel mechanistic model reveals new therapeutic targets","volume":"27","author":"Sigalov","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2020.05.005_bib0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/self.1.3.12794","article-title":"The SCHOOL of nature: III. From mechanistic understanding to novel therapies","volume":"1","author":"Sigalov","year":"2010","journal-title":"Self Nonself."},{"key":"10.1016\/j.drudis.2020.05.005_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12026-011-8256-4","article-title":"Evolution of immunity: no development without risk","volume":"52","author":"Sigalov","year":"2012","journal-title":"Immunol. Res."},{"key":"10.1016\/j.drudis.2020.05.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000404","article-title":"Novel mechanistic insights into viral modulation of immune receptor signaling","volume":"5","author":"Sigalov","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2020.05.005_bib0070","doi-asserted-by":"crossref","first-page":"28672","DOI":"10.1038\/srep28672","article-title":"SARS coronavirus fusion peptide-derived sequence suppresses collagen-induced arthritis in DBA\/1J mice","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2020.05.005_bib0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4161\/self.1.4.13279","article-title":"The SCHOOL of nature: IV. Learning from viruses","volume":"1","author":"Sigalov","year":"2010","journal-title":"Self Nonself."},{"key":"10.1016\/j.drudis.2020.05.005_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.apcsb.2017.06.004","article-title":"Targeting intramembrane protein-protein interactions: novel therapeutic strategy of millions years old","volume":"111","author":"Sigalov","year":"2018","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm0197-84","article-title":"T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease","volume":"3","author":"Manolios","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2020.05.005_bib0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clim.2002.5270","article-title":"T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer","volume":"105","author":"Wang","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-3083.2006.01806.x","article-title":"Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition","volume":"64","author":"Collier","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0008-8749(02)00002-3","article-title":"T cell antigen receptor (TCR) transmembrane peptides colocalize with TCR, not lipid rafts, in surface membranes","volume":"215","author":"Wang","year":"2002","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabet.2014.01.007","article-title":"Novel T-cell inhibiting peptides delay the onset of Type 1 diabetes in non-obese diabetic mice","volume":"40","author":"Wong","year":"2014","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.drudis.2020.05.005_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2014.01.005","article-title":"Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis","volume":"151","author":"Vanniasinghe","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbamcr.2006.04.013","article-title":"Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function","volume":"1763","author":"Amon","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2020.05.005_bib0120","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.gt.3301183","article-title":"Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases","volume":"7","author":"Gollner","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2020.05.005_bib0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/092986606778777452","article-title":"Immunoreceptor transmembrane peptides and their effect on natural killer (NK) cell cytotoxicity","volume":"13","author":"Vandebona","year":"2006","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.drudis.2020.05.005_bib0130","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/j.1538-7836.2007.02714.x","article-title":"More on: glycoprotein VI oligomerization: a novel concept of platelet inhibition","volume":"5","author":"Sigalov","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2020.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/35074114","article-title":"TREM-1 amplifies inflammation and is a crucial mediator of septic shock","volume":"410","author":"Bouchon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.05.005_bib0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fmicb.2014.00627","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM\u20131): a new player in antiviral immunity?","volume":"5","author":"Roe","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.02.043","article-title":"TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives","volume":"177","author":"Tammaro","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.05.005_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1586\/1744666X.2014.866519","article-title":"Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases","volume":"10","author":"Pelham","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0155","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/1744666X.2015.1043893","article-title":"Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells","volume":"11","author":"Nguyen","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5114\/ait.2020.93756","article-title":"COVID-19 - what should anaethesiologists and intensivists know about it?","volume":"52","author":"Wujtewicz","year":"2020","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"10.1016\/j.drudis.2020.05.005_bib0165","first-page":"30","article-title":"Acute respiratory distress syndrome in cancer patients: epidemiology, risk factors and outcomes","volume":"23","author":"Cardoso","year":"2018","journal-title":"Eur. J. Oncol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0170","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","article-title":"Acute respiratory distress syndrome in patients with malignancies","volume":"40","author":"Azoulay","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.drudis.2020.05.005_bib0175","doi-asserted-by":"crossref","first-page":"L426","DOI":"10.1152\/ajplung.00195.2015","article-title":"TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine","volume":"310","author":"Yuan","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003900","article-title":"TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance","volume":"10","author":"Weber","year":"2014","journal-title":"PLoS Pathog."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2020.05.005_bib0185","first-page":"1","article-title":"P1 Safety and pharmacodynamic activity of a novel TREM-1 pathway inhibitory peptide in septic shock patients: phase IIa clinical trial results","volume":"6","author":"Francois","year":"2018","journal-title":"Intensive Care Med Exp."},{"key":"10.1016\/j.drudis.2020.05.005_bib0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/506950","article-title":"Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats","volume":"194","author":"Gibot","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2020.05.005_bib0195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/SHK.0b013e31827bcdfb","article-title":"Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs","volume":"39","author":"Derive","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.drudis.2020.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/MIB.0000000000000822","article-title":"An antibody against triggering receptor expressed on myeloid cells 1 (TREM-1) dampens proinflammatory cytokine secretion by lamina propria cells from patients with IBD","volume":"22","author":"Brynjolfsson","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.drudis.2020.05.005_bib0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2014.05.001","article-title":"A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock","volume":"21","author":"Sigalov","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0210","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1111\/jcmm.13173","article-title":"Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis","volume":"21","author":"Shen","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drudis.2020.05.005_bib0215","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bbadis.2018.05.001","article-title":"Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy","volume":"1864","author":"Rojas","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2020.05.005_bib0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep4.1269","article-title":"Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice","volume":"3","author":"Tornai","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.drudis.2020.05.005_bib0225","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.30593","article-title":"Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2020.05.005_bib0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cmmi.1587","article-title":"Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages","volume":"9","author":"Sigalov","year":"2014","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.drudis.2020.05.005_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143453","article-title":"Diagnostic magnetic resonance imaging of atherosclerosis in apolipoprotein E knockout mouse model using macrophage-targeted gadolinium-containing synthetic lipopeptide nanoparticles","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2020.05.005_bib0240","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.molpharmaceut.7b00711","article-title":"Novel TREM-1 inhibitors attenuate tumor growth and prolong survival in experimental pancreatic cancer","volume":"14","author":"Shen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2020.05.005_bib0245","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3389\/fimmu.2019.02314","article-title":"Triggering receptor expressed on myeloid cells-1 inhibitor targeted to endothelium decreases cell activation","volume":"10","author":"Gibot","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2020.05.005_bib0250","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.200704-641OC","article-title":"TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer","volume":"177","author":"Ho","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drudis.2020.05.005_bib0255","doi-asserted-by":"crossref","first-page":"E646","DOI":"10.1016\/j.ijrobp.2019.06.1018","article-title":"Targeting tumor-associated macrophages to radiosensitize glioblastoma in a mouse model","volume":"105","author":"Mark","year":"2019","journal-title":"Int. J. Radiation Oncol. Biol. Phys."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:45:43Z","timestamp":1761223543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620301963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1359644620301963"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.05.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCHOOL of nature: ligand-independent immunomodulatory peptides","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}